Acquired Company
A.I. Software Inc. acquired all the issued and outstanding shares of Israeli stem cell firm Pluristem Ltd., and the acquiring company subsequently changed its name to Pluristem Life Systems Inc.
Show more
Start AI Chat
Market Cap
0.00
52 Wk Range
$N/A - $N/A
Previous Close
$3.53
Open
$3.59
Volume
10,314
Day Range
$3.58 - $3.64
Enterprise Value
0.00
Cash
0.00
Avg Qtr Burn
N/A
Insider Ownership
0.00%
Institutional Own.
0.00%
Qtr Updated
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
PLX-PAD Details Muscle injury following hip fracture | Phase 3 Update | |
PLX-PAD Details COVID-19, Hematopoietic cell transplantation | Phase 2 Update | |
PLX-R18 Details Acute radiation syndrome | Phase 2 Update | |
PLX-R18 Details Incomplete hematopoietic recovery following | Phase 1 Update | |
PLX-PAD (stem cells) Details Critical limb ischemia | Failed Discontinued |
